Virtual specialty care platform Summus announced it secured $19.5 million in funding, bringing its total raise to $70 million.
Summus offers employers, health plans, hospitals and health systems, and medical groups and networks a virtual care platform focused on specialty care, including peer-to-peer solutions that allow primary care and in-plan specialist providers access to a specialist...
GE HealthCare announced a strategic partnership with Mayo Clinic dubbed the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, through which the pair will collaborate on research and product development focusing on precision care, AI and theranostics.
Technology developers, clinicians, scientists and other providers from both companies will work together to advance...
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.
Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, participated in the round alongside Novartis (dRx Capital) and Intermountain Ventures. Existing investors Echo Health Ventures, Deerfield...
Augmedics, an augmented reality surgical-navigation platform, has scored $82.5 million in Series D financing led by CPMG.
Evidity Health Capital joins the round as a syndicate partner. Current investors Revival Healthcare Capital, H.I.G. Capital, Almeda Ventures and others participated in the round.
WHAT IT DOES
Augmedics xvision Spine System, which received FDA clearance in 2019, utilizes...
CHICAGO – Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient's response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference & Exhibition.
But there are challenges to putting together an effective genomics program, said Jackie Rice, vice president for information technology and chief...
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.
DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies directed toward specific epitopes (the part of an antigen molecule recognized by the immune system to which an antibody attaches...
Biotech and digital health funding soared in the wake of the COVID-19 pandemic, but both sectors slowed down in 2022.
Elena Viboch, partner at General Catalyst, said startups need to focus on the end goal — building technology or therapies that can help patients. She sat down with MobiHealthNews to discuss her takeaways from this year and her predictions for 2023.
MobiHealthNews: What do you...
AI-backed genomic and clinical data company Sema4 announced this week it would exit the reproductive health testing business, shut down its lab in Stamford, Connecticut, and lay off about 500 employees.
The company said it would complete its departure from the segment in the first quarter next year. It will now employ about 1,100 workers. According to a WARN Act Notice filed in Connecticut, the...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Alphabet's life science offshoot Verily announced it had raised $1 billion in an investment round led by its parent company alongside a shakeup of its executive team.
The company's founder Andy Conrad will step down as CEO, moving to an executive chairman position on Verily's board. Current president Stephen Gillett will take the reins in the chief executive role, effective January 2023.
Gillett...
